-
Integrated Proteomic and Metabolomic prediction of Term Preeclampsia.
Bahado-Singh R, Poon LC, Yilmaz A, Syngelaki A, Turkoglu O, Kumar P, Kirma J, Allos M, Accurti V, Li J, Zhao P, Graham SF, Cool DR, Nicolaides K.
Sci Rep 2017;7:16189. pdf -
Paternally expressed, imprinted insulin-like growth factor-2 in chorionic villi correlates significantly with birth weight.
Demetriou C, Abu-Amero S, Thomas AC, Ishida M, Aggarwal R, Al-Olabi L, Leon LJ, Stafford JL, Syngelaki A, Peebles D, Nicolaides KH, Regan L, Stanier P, Moore GE.
PLoS One 2014;9:e85454. pdf -
Proteomic Biomarkers of Preterm Birth Risk in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Biomarker Database Integration.
Galazis N, Docheva N, Nicolaides KH, Atiomo W.
PLoS One 2013;8:e53801. -
Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 weeks in preeclampsia.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
J Hum Hypertens 2012;26:253-8. -
Maternal serum insulin-like growth factor (IGF-I) and binding proteins IGFBP-1 and IGFBP-3 at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 2012;161:30-3. -
Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsia.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
Prenat Diagn 2011;31:196-201. -
Maternal serum IGF-I, IGFBP-1 and IGFBP-3 at 11-13 weeks in trisomy 21 and trisomy 18 pregnancies.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 2011;157:166-8. -
Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11-13 Weeks?
Mastricci AL, Akolekar R, Kuppusamy R, Ahmed M, Nicolaides KH.
Fetal Diagn Ther 2011;30:53-9. -
Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
Prenat Diagn 2010;30:1026-31. -
Maternal serum insulin-like growth factor binding protein-1 in pregnancy at high altitude.
Krampl E, Kametas NA, McAuliffe F, Cacho-Zegarra AM, Nicolaides KH.
Obstet Gynecol 2002;99:594-8. -
Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract.
Fowler DJ, Nicolaides KH, Miell JP.
Hum Reprod Update 2000;6:495-504. -
Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy.
Langford K, Nicolaides K, Miell JP.
Hum Reprod 1998;13:1389-93. -
The maternal insulin-like growth factor (IGF) and IGF binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
Miell JP, Langford KS, Jones JS, Noble P, Westwood m, White A, Nicolaides KH.
J Clin Endocrinol Metab 1997;82:287-92. -
Serun insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal and multiple human pregnancy.
Langford K, Nicolaides KH, Jones J, Abbas A, McGregor AM, Miell JP.
J Clin Endocrin Metab 1995;80:21-7. -
Superovulation, IGFBP-1 and birth weight.
Johnson MR, Irvine R, Hills F, Bolton VN, Abbas AA, Brooks AA, Allman AC, Chard T, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 1995;59:193-5. -
Maternal plasma concentrations of insulin-like growth factor binding protein-1 and placental protein 14 in multifetal pregnancies before and after fetal reduction.
Abbas A, Johnson M, Chard T, Nicolaides KH.
Hum Reprod 1995;10:207-10.